pharma news today glp-1 obesity drugs today Eli Lilly pill Foundayo gets the FDA green light : NPR GLP-1 Agonists Market Report 2025-2033,

Dietary MRPs are powerful antioxidants that chelate metal ions, breakdown radical chains/ hydrogen peroxide (H 2 O 2 ), and scavenge ROS 619

IGSRT is especially effective for basal and squamous cell skin cancers on the leg, and it is often preferred on cosmetically sensitive areas such as the knee cap or inner thigh where scarring may be more noticeable

Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial

Synthetic analogue of -MSH for pigmentation and receptor interaction research

doi: 10.1042/CS20200128 13 ChenC.GaoK.ChenZ.ZhangQ.KeX.MaoB.et al

Prog Lipid Res 2015